SCHEMBL8883571

SCHEMBL8883571

Nc1ccc(Cl)cc1NC1CCN(Cc2ccccc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.59
GAA P10253 1/20 0.59
ACHE P22303 6/20 0.56
BCHE P06276 4/20 0.56
BACE1 P56817 4/20 0.56
MCHR1 Q99705 1/20 0.56
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
MAPK1 P28482 2/20 0.54
ALDH1A1 P00352 1/20 0.54
LMNA P02545 1/20 0.54
MAPT P10636 1/20 0.54
PKM P14618 1/20 0.54
RAB9A P51151 1/20 0.54
SLC6A12 P48065 1/20 0.53
SIGMAR1 Q99720 3/20 0.52
HRH3 Q9Y5N1 1/20 0.52
HTT P42858 1/20 0.51
ROCK2 O75116 1/20 0.49
ROCK1 Q13464 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6160636 0.90 KDM4E (0.59) KDM4EGAAACHEBCHEBACE1
SCHEMBL5671677 0.85 KDM4E (0.70) KDM4EGAAACHEBCHEBACE1
Hydrochloric Acid SCHEMBL11102409 0.84 KDM4E (0.68) KDM4EGAAACHEBCHEBACE1
SCHEMBL5112887 0.82 ALDH1A1 (0.60) KDM4EGAAACHEBCHEBACE1
SCHEMBL6819009 0.82 KDM4E (0.61) KDM4EGAAACHEBCHEBACE1
SCHEMBL8884292 0.80 MAPK1 (0.77) KDM4EGAAACHEBCHEBACE1
SCHEMBL3491711 0.79 MEN1 (0.55) KDM4EGAAACHEMCHR1MEN1
SCHEMBL10059770 0.79 KDM4E (0.55) KDM4EGAAACHEBCHEBACE1
SCHEMBL7173363 0.79 KDM4E (0.46) KDM4EGAAMEN1KMT2AMAPK1
SCHEMBL29525969 0.79 KDM4E (0.46) KDM4EGAAMEN1KMT2AMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067603-B2 Opiod receptor-like receptors (ORL1); for treatment of chronic pain conditions, central nervous system disorders such as anxiety and stress disorders, depression, epilepsy, stroke, Alzheimer's disease, eating disorders, and drug abuse SOLVAY PHARMACEUTICALS B.V. (NL) 2011-11-29 US disclosed
US-8067603-B2 Opiod receptor-like receptors (ORL1); for treatment of chronic pain conditions, central nervous system disorders such as anxiety and stress disorders, depression, epilepsy, stroke, Alzheimer's disease, eating disorders, and drug abuse SOLVAY PHARMACEUTICALS B.V. (NL) 2011-11-29 US disclosed
US-5661169-A HAVE AFFINITY FOR VASOPRESSIN AND/OR OXYTOCIN RECEPTORS SANOFI (FR) 1997-08-26 US disclosed
US-5585394-A INHIBITOR, ANTAGONIST OF VASOPRESSIN OR OXYTOCIN SANOFI (FR) 1996-12-17 US disclosed
EP-0694536-A1 1-Benzyl-1,3-dihydro-2H-benzimidazol-2-one derivatives, their preparation and pharmaceutical compositions containing them SANOFI (FR) 1996-01-31 EP disclosed
EP-0636614-A1 Derivatives of 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one, their preparation and pharmaceutical compositions containing them SANOFI (FR) 1995-02-01 EP disclosed